From: “Low-age, low-frequency” lung cancer screening strategies maybe adaptable to the situation in China
Variables | Group A n = 2033 N(%) | Group B n = 2612 N(%) | P value |
---|---|---|---|
RADIOLOGICAL TUMOR TYPE | P < 0.05 | ||
Pure GGO | 498 (24.5) | 750 (28.7) | |
Part GGO | 256 (12.6) | 564 (21.6) | |
Pure solid | 1234 (60.7) | 1277 (48.9) | |
cavity | 45 (2.2) | 21 (0.8) | |
PATHOLOGICAL CLASSIFICATION | P < 0.05 | ||
AAH | 30 (1.5) | 44 (1.7) | |
AIS | 169 (8.3) | 232 (8.9) | |
MIA | 155 (7.6) | 465 (17.8) | |
IAC | 854 (42) | 1356 (51.9) | |
Squamous cell carcinoma | 228 (11.2) | 196 (7.5) | |
Small cell lung cancer | 22 (1.1) | 8 (0.3) | |
Metastatic carcinoma | 18 (0.9) | 5 (0.2) | |
Neuroendocrine tumor | 14 (0.7) | 3 (0.1) | |
Adenosquamous carcinoma | 4 (0.2) | 5 (0.2) | |
Big cell lung cancer | 4 (0.2) | 3 (0.1) | |
Other malignant tumors | 67 (3.3) | 21 (0.8) | |
Benign | 468 (23) | 274 (10.5) | |
TNM STAGING | P < 0.05 | ||
0 | 246 (12.1) | 253(9.7) | |
IA1 | 391 (19.2) | 875 (33.5) | |
IA2 | 449 (22.1) | 611 (23.4) | |
IA3 | 205 (10.1) | 193 (7.4) | |
IB | 234 (11.5) | 241 (9.2) | |
IIA | 47 (2.3) | 34 (1.3) | |
IIB | 122 (6) | 128 (4.9) | |
IIIA | 252 (12.4) | 201 (7.7) | |
IIIB | 79 (3.9) | 26 (1) | |
IV | 8 (0.4) | 50 (1.9) |